Showing results (1-10 of 531) with videos related to

Sort By:
Pageof 54
Seminars in Nuclear Medicine|August 16, 2005
Evaluation of therapy for lymphomaGuy Jerusalem, Roland Hustinx, Yves Beguin, et al.
Current Opinion in Oncology|August 12, 2005
Positron emission tomography imaging for lymphomaGuy Jerusalem, Roland Hustinx, Yves Beguin, et al.
Haematologica|September 21, 2004
CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancerFrédéric Baron, Sandra Copizza, Etienne Baudoux, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2003
Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftmentFrédéric Baron, Pascale Frère, Georges Fillet, et al.
European Journal of Haematology|January 13, 2006
Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantationPascale Frère, Maguy Pereira, Georges Fillet, et al.
British Journal of Haematology|September 27, 2003
Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusionFrédéric Baron, Pascale Frère, Georges Fillet, et al.
Hematology (Amsterdam, Netherlands)|September 24, 2002
Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantationFrédéric Baron, Etienne Baudoux, Georges Fillet, et al.
La Revue Du Praticien|December 22, 2007
[Positron emission tomography in oncology: an update]Guy Jerusalem, Nadia Withofs, Andrée Rorive, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2006
Sequential positron emission tomography using [18F]fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancerOlivier Couturier, Guy Jerusalem, Jean-Michel N'Guyen, et al.
Experimental Hematology|June 14, 2002
Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantationFrédéric Baron, Brieuc Sautois, Etienne Baudoux, et al.
Pageof 54